These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30115117)

  • 1. IgM response against amyloid-beta in aging: a potential peripheral protective mechanism.
    Agrawal S; Abud EM; Snigdha S; Agrawal A
    Alzheimers Res Ther; 2018 Aug; 10(1):81. PubMed ID: 30115117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune and Inflammatory Determinants Underlying Alzheimer's Disease Pathology.
    Baulch JE; Acharya MM; Agrawal S; Apodaca LA; Monteiro C; Agrawal A
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):852-862. PubMed ID: 32090272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.
    Lindhagen-Persson M; Brännström K; Vestling M; Steinitz M; Olofsson A
    PLoS One; 2010 Nov; 5(11):e13928. PubMed ID: 21085663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease.
    Marcello A; Wirths O; Schneider-Axmann T; Degerman-Gunnarsson M; Lannfelt L; Bayer TA
    Neurobiol Aging; 2011 Aug; 32(8):1379-87. PubMed ID: 19781815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate.
    Solerte SB; Ferrari E; Cuzzoni G; Locatelli E; Giustina A; Zamboni M; Schifino N; Rondanelli M; Gazzaruso C; Fioravanti M
    Dement Geriatr Cogn Disord; 2005; 19(1):1-10. PubMed ID: 15383738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
    PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects.
    Baril L; Nicolas L; Croisile B; Crozier P; Hessler C; Sassolas A; McCormick JB; Trannoy E
    Neurosci Lett; 2004 Jan; 355(3):226-30. PubMed ID: 14732472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.
    Söllvander S; Ekholm-Pettersson F; Brundin RM; Westman G; Kilander L; Paulie S; Lannfelt L; Sehlin D
    J Alzheimers Dis; 2015; 48(1):63-72. PubMed ID: 26401929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer's disease.
    Marcello A; Wirths O; Schneider-Axmann T; Degerman-Gunnarsson M; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2009 Jul; 116(7):913-20. PubMed ID: 19415450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway.
    Reale M; Di Nicola M; Velluto L; D'Angelo C; Costantini E; Lahiri DK; Kamal MA; Yu QS; Greig NH
    Curr Alzheimer Res; 2014; 11(6):608-22. PubMed ID: 24359497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease.
    Monsonego A; Zota V; Karni A; Krieger JI; Bar-Or A; Bitan G; Budson AE; Sperling R; Selkoe DJ; Weiner HL
    J Clin Invest; 2003 Aug; 112(3):415-22. PubMed ID: 12897209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients.
    Ciaramella A; Salani F; Bizzoni F; Orfei MD; Langella R; Angelucci F; Spalletta G; Taddei AR; Caltagirone C; Bossù P
    Brain Behav Immun; 2013 Aug; 32():29-32. PubMed ID: 23578995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.
    Vojdani A; Vojdani E; Saidara E; Kharrazian D
    J Alzheimers Dis; 2018; 63(2):847-860. PubMed ID: 29689721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide.
    Rocha NP; Teixeira AL; Coelho FM; Caramelli P; Guimarães HC; Barbosa IG; da Silva TA; Mukhamedyarov MA; Zefirov AL; Rizvanov AA; Kiyasov AP; Vieira LB; Janka Z; Palotás A; Reis HJ
    Mol Cell Neurosci; 2012 Jan; 49(1):77-84. PubMed ID: 21971579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.
    Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU
    J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.